Results 221 to 230 of about 47,640 (246)
Some of the next articles are maybe not open access.
Annals of internal medicine, 1979
After 5 years of use, cefazolin can be considered similar to cephalothin as a therapeutic agent and in its potential for adverse reactions. When cefazolin and cephalothin are compared by appropriately designed clinical trials, neither cefazolin's slightly greater in-vitro susceptibility to staphylococcal beta-lactamase inactivation, nor its slightly ...
R, Quintiliani, C H, Nightingale
openaire +1 more source
After 5 years of use, cefazolin can be considered similar to cephalothin as a therapeutic agent and in its potential for adverse reactions. When cefazolin and cephalothin are compared by appropriately designed clinical trials, neither cefazolin's slightly greater in-vitro susceptibility to staphylococcal beta-lactamase inactivation, nor its slightly ...
R, Quintiliani, C H, Nightingale
openaire +1 more source